Pharma's Almanac: Nice Insight's Content Community

ad image

Articles
Expert Interviews
Roundtable
Press Releases
Videos

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Hemophilia A

Sort By

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Our Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2024 PHARMA’S ALMANAC. All rights reserved.

1 / 1

1 / 1

BioMarin Going for 2020 Approval of its Hemophilia A Gene Therapy

Drug Approval

BioMarin Going for 2020 Approval of its Hemophilia A Gene Therapy

David Alvaro, Ph.D.

Pharma's Almanac

PAO-M08-19-NI-026Aug 22, 2019

Bayer Statement on Voluntary Recall of Two Lots of Kogenate® FS Antihemophilic Factor (Recombinant) in the United States

Recall

Bayer Statement on Voluntary Recall of Two Lots of Kogenate® FS Antihemophilic Factor (Recombinant) in the United States

Nice Insight

PR-M07-19-NI-062Jul 24, 2019

Bayer Gets FDA Approval for Hemophilia A Drug

Drug Development

Bayer Gets FDA Approval for Hemophilia A Drug

Emilie Branch

Pharma's Almanac

PAO-M09-18-NI-006Sep 06, 2018

Clinical Trial

Sangamo Announces Positive Preliminary Data from the Phase 1/2 Alta Study Evaluating SB-525 Gene Therapy for Hemophilia A

Sangamo Therapeutics

PR-M08-18-NI-113Aug 29, 2018

Shire Submits IND for Hemophilia A Gene Therapy

Cell and Gene Therapy

Shire Submits IND for Hemophilia A Gene Therapy

Nigel Walker

Nice Insight

PAO-M07-17-NI-016Jul 13, 2017